1 / 17

Presented By Christina Tsien at 2014 ASCO Annual Meeting

Presented By Christina Tsien at 2014 ASCO Annual Meeting. Current Limitations in the Response Assessment of Anti-Angiogenic Therapy. Presented By Christina Tsien at 2014 ASCO Annual Meeting. Imaging Changes Following Anti-Angiogenic Therapy.

quintin-hollis
Download Presentation

Presented By Christina Tsien at 2014 ASCO Annual Meeting

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Presented By Christina Tsien at 2014 ASCO Annual Meeting

  2. Current Limitations in the Response Assessment of Anti-Angiogenic Therapy Presented By Christina Tsien at 2014 ASCO Annual Meeting

  3. Imaging Changes Following Anti-Angiogenic Therapy Presented By Christina Tsien at 2014 ASCO Annual Meeting

  4. Does Reduction in Enhancement Reflect Anti-Tumor Effect? Presented By Christina Tsien at 2014 ASCO Annual Meeting

  5. Recurrent GBM treated with Bevacizumab: CE-Δ T1-weighted Subtraction Maps Aid Prediction of Survival in a Multi-Center Clinical Trial Presented By Christina Tsien at 2014 ASCO Annual Meeting

  6. Improved Response Rates with Anti-Angiogenic Therapies Does Not Correlate to Improved OS Presented By Christina Tsien at 2014 ASCO Annual Meeting

  7. <br />Physiologic MRI: Imaging Tumor Biology May Improve Response Assessment Presented By Christina Tsien at 2014 ASCO Annual Meeting

  8. Slide 8 Presented By Christina Tsien at 2014 ASCO Annual Meeting

  9. Bi-modal fitted ADC Histogram Analysis Predict 6 mth PFS in Recurrent GBM Tx with Bevacizumab Presented By Christina Tsien at 2014 ASCO Annual Meeting

  10. Bevacizumab Decreases Edema Leading to Improved Clinical Benefit Presented By Christina Tsien at 2014 ASCO Annual Meeting

  11. Vessel Architectural Imaging Presented By Christina Tsien at 2014 ASCO Annual Meeting

  12. Summary Presented By Christina Tsien at 2014 ASCO Annual Meeting

  13. Imaging Biomarkers Ready for Prime Time? Presented By Christina Tsien at 2014 ASCO Annual Meeting

  14. Physiologic Imaging Biomarkers must add value beyond known Clinical Predictors of OS Presented By Christina Tsien at 2014 ASCO Annual Meeting

  15. What are the Challenges in Incorporating Imaging Biomarkers in the Clinic Today? Presented By Christina Tsien at 2014 ASCO Annual Meeting

  16. Diffusion MRI Presented By Christina Tsien at 2014 ASCO Annual Meeting

  17. Summary Presented By Christina Tsien at 2014 ASCO Annual Meeting

More Related